Merck in advanced talks to buy Acceleron Pharma – WSJ

Stock Markets10 minutes ago (Sep 27, 2021 06:40PM ET)

(C) Reuters. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

(Reuters) -Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma (NASDAQ:XLRN) Inc, the Wall Street Journal reported https://www.wsj.com/articles/merck-nears-deal-to-acquire-acceleron-pharma-11632778405?mod=latest_headlines on Monday, citing people familiar with the matter.

A potential deal could help Merck, which sells the blockbuster cancer drug Keytruda, to add drugs for rare diseases to its pipeline.

Cambridge, Massachusetts-based Acceleron focuses on the discovery, development and commercialization of therapeutics to treat blood-related disorders. It had a market capitalization of $10.89 billion, as of its last close.

A Bloomberg report on Friday said Acceleron was in talks to be acquired for more than $11 billion. Bloomberg had reported that several drugmakers including Merck’s rival Bristol-Myers Squibb (NYSE:BMY) Co, which owns 11.5% of Acceleron’s stock, were seen as potential suitors.

Acceleron currently earns royalties from sales of Reblozyl, a drug to treat two blood related disorders, and is developing another treatment for a type of high blood pressure that affects the lungs.

Reblozyl, which is jointly co-promoted by Bristol and Acceleron, brought in sales of $274 million in 2020, according to Bristol Myers.

Merck in advanced talks to buy Acceleron Pharma – WSJ

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

More from author

Subscribe

Related posts

Latest posts

Chinese hot pot chain Haidilao slows growth as COVID-19 curbs consumer appetite

2/2 (C) Reuters. FILE PHOTO: Waiters serve customers at a Haidilao hotpot restaurant in Beijing, China October 11, 2021. Picture taken October 11, 2021. REUTERS/Tingshu...

Biden, Democrats aim for deal on spending package in coming days

2/2 (C) Reuters. FILE PHOTO: U.S. President Joe Biden delivers an update on the administration's coronavirus disease (COVID-19) response and the vaccination program during remarks...

China raises $4 billion in U.S. dollar bond deal

Stock Markets12 minutes ago (Oct 19, 2021 08:30PM ET) (C) Reuters. By Scott Murdoch HONG KONG (Reuters) - China has raised $4 billion through a...

Categories

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!